文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

男性尿道炎患者中生殖支原体感染、耐药突变及治疗后症状持续情况

Prevalence of Mycoplasma genitalium Infection, Antimicrobial Resistance Mutations, and Symptom Resolution Following Treatment of Urethritis.
PubMed 文献 · Clin Infect Dis · 2020-01-01

该研究在美国6家性传播疾病门诊纳入914名有尿道炎症状的男性,检测生殖支原体(MG)感染及大环内酯类耐药突变(MRM)和喹诺酮类耐药突变。结果显示28.7%存在MG感染,MG阳性者中64.4%携带MRM,治疗后症状持续在MG阳性与阴性者中均较常见。

要点

  • 有尿道炎症状的男性中MG感染率较高,应重视病原学检测
  • MG阳性者大环内酯类耐药突变比例高,经验性用药需谨慎
  • 无论是否检出MG,治疗后症状持续均较常见,需随访评估

核心结论

  • 有尿道炎症状的男性中MG感染常见,MG阳性者MRM比例高,治疗后症状持续在MG阳性与阴性者中均常见。

研究设计与样本

  • 2017年6月至2018年7月在美国6家性传播疾病门诊纳入有尿道炎症状的男性,共914名可评估参与者,检测尿道标本MG及其他细菌性性传播疾病,并进行随访与病历复习。

主要发现

  • 914名可评估参与者中28.7%(95%CI 23.8-33.6)检出MG。
  • MG阳性者中64.4%(95%CI 58.2-70.3%)携带MRM,11.5%(95%CI 7.9-16.0%)有parC突变,0%有gyrA突变。
  • 入组时接受阿奇霉素为基础治疗并完成随访调查者中,症状持续比例分别为MG阳性/MRM阳性25.8%、MG阳性/MRM阴性13%、MG阴性17.2%。

临床怎么用

  • 对尿道炎男性应考虑MG检测,并在MG阳性时关注大环内酯类耐药突变以指导治疗选择。
  • 治疗后应随访症状是否持续,不因MG阴性而排除持续症状的可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antimicrobial resistance in Mycoplasma genitalium (MG), a cause of urethritis, is a growing concern. Yet little is known about the geographic distribution of MG resistance in the United States or about its associated clinical outcomes. We evaluated the frequency of MG among men with urethritis, resistance mutations, and posttreatment symptom persistence. METHODS: We enrolled men presenting with urethritis symptoms to 6 US sexually transmitted disease (STD) clinics during June 2017-July 2018; men with urethritis were eligible for follow-up contact and, if they had persistent symptoms or MG, a chart review. Urethral specimens were tested for MG and other bacterial STDs. Mutations in 23S ribosomal ribonucleic acid (rRNA) loci (macrolide resistance-associated mutations [MRMs]) and in parC and gyrA (quinolone-associated mutations) were detected by targeted amplification/Sanger sequencing. RESULTS: Among 914 evaluable participants, 28.7% (95% confidence interval [CI], 23.8-33.6) had MG. Men with MG were more often Black (79.8% vs 66%, respectively), <30 years (72.9% vs 56.1%, respectively), and reported only female partners (83.7% vs 74.2%, respectively) than men without MG. Among MG-positive participants, 64.4% (95% CI, 58.2-70.3%) had MRM, 11.5% (95% CI, 7.9-16.0%) had parC mutations, and 0% had gyrA mutations. Among participants treated with azithromycin-based therapy at enrollment and who completed the follow-up survey, persistent symptoms were reported by 25.8% of MG-positive/MRM-positive men, 13% of MG-positive/MRM-negative men, and 17.2% of MG-negative men. CONCLUSIONS: MG infection was common among men with urethritis; the MRM prevalence was high among men with MG. Persistent symptoms following treatment were frequent among men both with and without MG.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Bachmann LH, Kirkcaldy RD, Geisler WM, et al. Prevalence of Mycoplasma genitalium Infection, Antimicrobial Resistance Mutations, and Symptom Resolution Following Treatment of Urethritis. Clin Infect Dis. 2020. PMID: 32185385. doi:10.1093/cid/ciaa293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。